课题基金 / 基金详情

Making and clinical application of supporting software for the optimal administration method of drug based on the PK/PD theory on the target-organ

Making and clinical application of supporting software for the optimal administration method of drug based on the PK/PD theory on the target-organ
基于靶器官PK/PD理论的药物最佳给药方式支撑软件的制作及临床应用
批准号:
20590146
负责人:
MORIKAWA Norifumi
金额:
$3.16万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

MORIKAWA Norifumi的其他基金

相似基金

相关文献

中文摘要
翻译
我们制作了一套新的系统,用于在我们的研究合作医院采集患者的血液和生物样本。建立了患者送药样品的药物浓度测定方法。药物浓度测定结果通过电子邮件发送给研究合作医院。采集每位患者药物的药代动力学(PK)和药效学(PD)数据。根据收集到的个体药代动力学数据估算群体药代动力学参数(PPK)。基于估算PPK所使用的靶器官的PK/PD理论,制作了药物最优给药方法的配套软件。
英文摘要
We made a new system which collected blood and biological samples in patient at our research collaboration hospitals. It established the drug concentration measurement methods of those delivered samples of patients. Those measured drug concentration results were sent to the research collaboration hospitals by e-mail. It collected the pharmacokinetic (PK) and the pharmacodynamics (PD) data of drug in each patient. It estimated the population pharmacokinetic parameter (PPK) from the gathered individual PK data. We made the supporting software for the optimal administration method of drug based on the PK/PD theory on the target-organ used by the estimated PPK.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2008
期刊: J.Chemother. 20
影响因子: --
作者: [Ikawa K, Morikawa N, Fukuhara K, Hayato S, Ikeda K, Soga Y, Ohge H, Sueda T]
通讯作者: Sueda T
Dexamethasone reduced voriconazole plasma level in a patient who carries CYP2C19 mutant
地塞米松降低了携带 CYP2C19 突变体的患者的伏立康唑血浆水平
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [Matsumoto K, Kondo T, Kanazawa N, Yokoyama Y, Fukamizu T, Takeda Y, Mukai M, Arimura H, Nakazaki M, Ikawa K, Morikawa N, Tei C, Yamada K]
通讯作者: Yamada K
Penetration of doripenem into prostatic tissue after intravenous administration in prostatectomy patients
前列腺切除术患者静脉给药后多尼培南对前列腺组织的渗透
DOI: --
发表时间: 2010
期刊: Int.J.Antimicrob.Agents 35
影响因子: --
作者: [Yamada Y, Ikawa K, Nakamura K, Mitsui K, Narushima M, Hibi H, Ikeda K, Morikawa N, Honda N]
通讯作者: Honda N
DOI: 10.1016/j.ijantimicag.2009.01.008
发表时间: 2009-07-01
期刊: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
影响因子: 10.8
作者: [Matsumoto, Kazuaki, Ikawa, Kazuro, Yamada, Katsushi]
通讯作者: Yamada, Katsushi
共 42 条
    Establish the optimal method of administration of the antimicrobial agent was used as an index of treatment goal probability of achieving the target organ and PK / PD theory
    • 批准号:
      23590184
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.49万
    • 财政年份:
      2011
    • 负责人:
      MORIKAWA Norifumi
    • 依托单位:
    海外基金